Sitting on a Pile of Cash 2.0? A Pharma with Strong Risk Benefits

Sitting on a Pile of Cash 2.0? A Pharma with Strong Risk Benefits

$MEIP MEI Pharma Inc. (NASDAQ:MEIP): this is an exponential Northside call, the sector analysts sees it having a best-in-class PI3Kδ inhibitor, which has demonstrated strong risk-benefit profile in Phase 1 lymphoma trials. MEIP broke out on 6 April and has confirmed it Bull move, the Support is Strong at 2.53 and the Resistance is NIL, […]

Donald J. Trump has Become a Wartime President: “Praise the Lord, He Passed Us the Ammunition”

Donald J. Trump has Become a Wartime President: “Praise the Lord, He Passed Us the Ammunition”

$BAYRY Never before have the American People been affected by such a catastrophe, as no war has or will have the effect of a virus such as COVID-19 worldwide.  In essence, the $21-T+ American economy at a standstill with millions of American families wondering how they will survive economically. About 40% live paycheck to paycheck […]

2020: Some More Biopharmas with Huge Northside Potential

2020: Some More Biopharmas with Huge Northside Potential

$APTO, $CDMO, $ENDP, $IGMS, $ILMN Here are some of the many biotech and pharma stocks that have been given big Northside targets for Y 2020 by Key sector analysts, as follows: Aptose Biosciences Inc. (NASDAQ:APTO) was started with a new Buy rating and a 10 price target at Piper Jaffray on 9 January. This represented […]

2020: Analysts are Giving These Biotech and Pharma Stocks Strong Northside Targets

2020: Analysts are Giving These Biotech and Pharma Stocks Strong Northside Targets

$ISEE, $KOD, $MYL, $NVCN, $PCRX, $XFOR Iveric Bio, Inc. (NASDAQ:ISEE) was started with a Buy rating and was assigned a $13 price target at Wedbush Securities on 7 January. Wedbush sees the stock as undervalued as its lead asset Zimura is set to begin a pivotal clinical study in Q-1 of Y 2020 in the […]

Big Pharma Earnings Up Next Week

Big Pharma Earnings Up Next Week

$ABBV, $BAX, $BIIB, $BMY, $BXX, $CELG, $MRK, $WST Biotech stocks had a muted performance last week, as Johnson & Johnson (NYSE:JNJ) kick started Q-2 reporting season for big pharma companies, beating forecasts and an upward adjustment to its FY sales guidance. Below are the Key catalysts for the week ahead, as follows: Conferences 10th International AIDS Society, or […]

Update: The Legal Status of CBD in the US

Update: The Legal Status of CBD in the US

Update: The Legal Status of CBD in the US $GWPH CBD is the nonpsychoactive component of cannabis and hemp. Unlike the THC in cannabis, CBD does not induce a high, but has many clinical benefits, including the control of seizures and pain Federal drug laws stipulate cannabis is an illegal Class 1 narcotic In states […]

Big Pharma Vs Hemp Based CBDs and Medical Marijuana

Big Pharma Vs Hemp Based CBDs and Medical Marijuana

Big Pharma Vs Hemp Based CBDs and Medical Marijuana $LLY, $GWPH The legal status of CBD oil, as a nutritional supplement is being threatened by Big Pharma seeking FDA approval for CBD-containing drugs The cannabinoids in cannabis, cannabidiol (CBD) and tetrahydrocannabinol (THC), interact with the human body by way of naturally-occurring cannabinoid receptors embedded in […]

Medical Grade Marijuana, The Solution to America’s Opioid Addiction?

Medical Grade Marijuana, The Solution to America’s Opioid Addiction?

Medical Grade Marijuana, The Solution to America’s Opioid Addiction? $ENDP Last Thursday, the FDA took an unprecedented step in an attempt to curb America’s opioid abuse crisis, but that does not yet mean that medical grade marijuana will be more seriously considered as an alternative to the highly addictive and deadly heroin like Rx drugs. […]

Future Uncertain, as Speculators Pour Money into Cannabis Industry

Future Uncertain, as Speculators Pour Money into Cannabis Industry

Future Uncertain, as Speculators Pour Money into Cannabis Industry The adversarial stance of The Trump Administration’s toward cannabis has yellow lights flashing in the growing industry, but speculators’ money continues to pour in. Marijuana focused companies raised more than $731-M between 1 January and 21 April, an almost 7X increase from the same frame last […]